Small and medium-sized biotech companies

Statistics report about small and medium-sized innovative biotech companies

Small and medium-sized biotech companies

This report presents key facts and figures on small and mid-sized biotech companies which are the key driver of innovation for the whole biopharma sector. Small and mid-sized enterprises (SMEs) are responsible for most of the new breakthrough therapies and technologies. This report provides a good introduction into the biotech SME landscape, thereby focusing on two SMEs which made it to the big scene due to their COVID-19 vaccines: BioNTech and Moderna.

Table of contents

Biotech market

6
  • Basic Statistic Percentage of global pharmaceutical sales by technology 2014-2028
  • Premium Statistic Global biotech drug sales estimate 2012-2023
  • Premium Statistic Projection of top 2024 pharma and biotech launches by revenue 2028
  • Basic Statistic Enterprise value change in biopharma subsectors worldwide 2022-2023
  • Basic Statistic Sales per employee of select U.S. biotech and drugs companies Q3 2023
  • Premium Statistic Gross profit margin of select U.S. biotech and drugs companies Q3 2023

SME financing

6
  • Basic Statistic Total raised capital in U.S. and Europe biotechnology industry 2015-2022
  • Basic Statistic IPOs in U.S. and Europe biotechnology industry 2000-2022
  • Basic Statistic Venture capital in U.S. and Europe biotechnology industry 2015-2022
  • Basic Statistic United States biotech financing data 2015-2020
  • Premium Statistic Value of top U.S. biotech IPOs 2022
  • Basic Statistic U.S. investment for emerging therapeutic companies 2011-2022

Research & development

5
  • Basic Statistic Top 50 global pharmaceutical and biotech companies by R&D intensity in 2022
  • Basic Statistic Number of FDA approved NMEs, 2009-2018, by size of drug owner
  • Basic Statistic Number of FDA approved NMEs, 2009-2018, by size of drug originator
  • Basic Statistic Origin of new drugs licensed or acquired, 2014-2018, by company size
  • Basic Statistic Alliances U.S. and Europe biotech companies by total potential value 2022

Growth

4
  • Premium Statistic Top performing companies on Nasdaq Biotech Index 2020
  • Basic Statistic Top pharmaceutical and biotech companies by profit growth in 2022
  • Premium Statistic Top pharmaceutical companies by capex growth in 2022
  • Basic Statistic Top pharmaceutical companies in R&D spending growth 2022

BioNTech vs. Moderna

8
  • Basic Statistic Revenue of BioNTech 2017-2023
  • Basic Statistic Moderna's revenue 2016-2023
  • Basic Statistic Operating income of BioNTech 2017-2023
  • Basic Statistic Moderna net income 2016-2023
  • Basic Statistic Total assets of BioNTech 2017-2023
  • Basic Statistic Moderna total assets 2016-2023
  • Basic Statistic R&D expenses of BioNTech 2017-2023
  • Basic Statistic R&D expenses of Moderna 2016-2023

Comparison of COVID-19 vaccines

5
  • Basic Statistic Forecasted sales of select COVID-19 vaccines worldwide 2021-2022
  • Basic Statistic COVID-19 vaccine comparison Biontech/Pfizer vs Moderna 2020
  • Basic Statistic COVID-19 vaccine comparison adverse events Biontech vs Moderna 2020
  • Premium Statistic BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
  • Basic Statistic Market reaction of COVID-19 vaccine makers to U.S. support of vaccine patents waiver

Statista report shop

Explore all Statista reports

We provide information on industries, companies, consumers, trends, countries, and politics, covering the latest and most important issues in a condensed format.

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)